Announcements Trials
Browse Landscape

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 10Prostatic Neoplasms 8Head and Neck Neoplasms 8Colorectal Neoplasms 8Breast Neoplasms 7Motor Activity 6Ovarian Neoplasms 5Rectal Neoplasms 4Oropharyngeal Neoplasms 4Multiple Myeloma 4Endometrial Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Mouth Neoplasms 3Colorectal Neoplasms, Hereditary Nonpolyposis 3COVID-19 3Uterine Cervical Neoplasms 2Stomach Neoplasms 2Pancreatic Neoplasms 2Obesity 2Nasopharyngeal Neoplasms 2Lymphoma 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia 2Leiomyoma 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Hematological Cancer 2Hematologic Neoplasms 2Colonic Neoplasms 2Brain Neoplasms 2

Interventions

Melphalan 2Carboplatin 2sodium thiosulfate 1Verteporfin 1Thiotepa 1TH 302 1Surveys and Questionnaires 1Mannitol 1Etoposide 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Neuroectodermal Tumors, Primitive × Surveys and Questionnaires × Clear all
NCT03043508 2019-05-23

Overall and Disease Specific Survival in Patients With Confirmed MEN1 With or Without PNET (Pancreatic Neuroendocrine Tumors)

M.D. Anderson Cancer Center

Unknown
45 enrolled

Adenoma, Islet Cell, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡